| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.20B | — | +14.5% |
| R&D Expense | $951.0M | — | +16.7% |
| SG&A Expense | $798.0M | — | +21.5% |
| Operating Income | $1.92B | — | +56.6% |
| Pre-tax Income | $496.0M | — | -64.2% |
| Income Tax | $194.0M | — | +148.3% |
| Net Income | $263.0M | — | -85.2% |
| EPS (Basic) | $0.13 | — | -84.7% |
| EPS (Diluted) | $0.13 | — | -84.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.56B | -21.8% | +8.3% |
| Short-term Investments | $533.0M | +0.9% | -40.4% |
| Accounts Receivable | $3.90B | +1.8% | +11.6% |
| Current Assets | $12.82B | -8.4% | +3.8% |
| Total Assets | $59.88B | -3.1% | +13.4% |
| Current Liabilities | $11.99B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.35B | — | +1.2% |
| Capital Expenditures | $65.0M | — | -12.2% |
| Investing Cash Flow | -$773.0M | — | -42.6% |
| Financing Cash Flow | -$3.09B | — | -66.0% |
| Free Cash Flow | $2.29B | — | +1.6% |
| -1.0% |
| Long-term Debt | $10.51B | -0.8% | +25.9% |
| Total Liabilities | $34.07B | +1.0% | +13.9% |
| Stockholders' Equity | $24.75B | -8.5% | +12.6% |